{"entity":{"edinet_code":"E31624","sec_code":"3417","name_ja":"大木ヘルスケアホールディングス株式会社","name_en":"OHKI HEALTHCARE HOLDINGS CO.,LTD.","industry":"卸売業","industry_en":"Wholesale Trade"},"names_note":"English company names are as filed: each company's own annual report states its English name on the cover page. For a company that files no annual report, EDINET's filer registry is used instead. The as-filed Japanese name is always returned alongside.","filing":{"doc_id":"S100YF0K","filer_name":"大木ヘルスケアホールディングス株式会社","filer_name_en":"OHKI HEALTHCARE HOLDINGS CO.,LTD.","period_end":"2026-03-31","filed_date":"2026-06-23","sha256":"e47e2501a00ac6076a3d4b78c56ebd85e13b0c6051b6027a347f4bf05b1eb801","status":"clean"},"basis":{"measurement":"carrying_amount","entity_scope":"holdco_consolidated","share_scope":"both","trust_included":"unknown","as_of":"2026-03-31","period_type":"annual","labels":{"measurement":"Balance-sheet carrying amount. Under Japanese GAAP listed equities are carried at market with the valuation difference in other comprehensive income, so carrying amount and acquisition cost diverge enormously on positions bought decades ago.","entity_scope":"Every disclosing entity in the filing, summed — the reporting company plus each group holder it names.","share_scope":"Listed and unlisted shares together.","trust_included":"The filing does not state whether retirement-benefit-trust shares are included. Never guessed — shares contributed to such a trust leave the holder's balance sheet while the settlor normally keeps the right to instruct the vote.","period_type":"From an annual securities report (有価証券報告書). The policy shareholding table appears only in the annual report."},"not_comparable":"Figures are balance-sheet CARRYING AMOUNT at fiscal year end, from the annual securities report. They are NOT comparable with the acquisition-cost or book-value-reduction figures quoted in press coverage and IR presentations, and NOT comparable with interim (half-year) figures, which this product does not hold. Always state the basis with the number, and use check_claim before setting one of our figures against a published one."},"basis_note":"The basis every yen figure on this response is on. entity_scope is read from the filing's own disclosing entities, not assumed: scale_entities and flows each carry their own entity_scope and share_scope, and a figure quoted for one entity is not the group figure.","holdings":[{"holder_table":"largest","held_name_raw":"大塚ホールディングス㈱","held_name_en":"Otsuka Holdings Co., Ltd.","held_sec_code":"4578","match_status":"matched","shares":832000,"book_value_yen":9160000000,"prior_shares":832000,"prior_book_value_yen":6450000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。","reciprocal":"無(注１)","pct_outstanding":0.1575365473855156,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":26.810279224960485,"pct_of_holder_assets":6.172797908257128,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"東邦ホールディングス㈱","held_name_en":"TOHO HOLDINGS CO.,LTD.","held_sec_code":"8129","match_status":"matched","shares":372000,"book_value_yen":1771000000,"prior_shares":372000,"prior_book_value_yen":1659000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける業務提携先であると共に、販売先及び仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"有","pct_outstanding":0.5751458868364598,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":5.183515775917579,"pct_of_holder_assets":1.1934525213453464,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"ロート製薬㈱","held_name_en":"ROHTO PHARMACEUTICAL CO.,LTD.","held_sec_code":"4527","match_status":"matched","shares":274714,"book_value_yen":661000000,"prior_shares":272447,"prior_book_value_yen":609000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、新規商品・カテゴリーの導入等に伴う、より一層の取引関係や協力関係の強化を図るため、取引先持株会を通じて保有株式数が増加しております。","reciprocal":"有","pct_outstanding":0.12157406627621857,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.9346718960369957,"pct_of_holder_assets":0.44543880102161154,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱トライアルホールディングス","held_name_en":"TRIAL Holdings, Inc.","held_sec_code":"141A","match_status":"matched","shares":100000,"book_value_yen":420000000,"prior_shares":100000,"prior_book_value_yen":218000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.08145146510822864,"pct_unavailable":null,"pct_basis_period_end":"2026-06-30","pct_share_classes":1,"pct_of_holder_equity":1.2292922788737342,"pct_of_holder_assets":0.2830322185008727,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱三菱ＵＦＪフィナンシャル・グループ","held_name_en":"Mitsubishi UFJ Financial Group, Inc.","held_sec_code":"8306","match_status":"matched","shares":124000,"book_value_yen":322000000,"prior_shares":124000,"prior_book_value_yen":249000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な借入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無(注１)","pct_outstanding":0.0010976998627110323,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.9424574138031961,"pct_of_holder_assets":0.21699136751733572,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"ツルハホールディングス㈱","held_name_en":"TSURUHA HOLDINGS INC.","held_sec_code":"3391","match_status":"matched","shares":116150,"book_value_yen":288000000,"prior_shares":99324,"prior_book_value_yen":214000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、株式分割他、新規商品・カテゴリーの導入等に伴う、より一層の取引関係や協力関係の強化を図るため、取引先持株会を通じて保有株式数が増加しております。","reciprocal":"無","pct_outstanding":0.025567791529891457,"pct_unavailable":null,"pct_basis_period_end":"2026-02-28","pct_share_classes":1,"pct_of_holder_equity":0.8429432769419891,"pct_of_holder_assets":0.19407923554345555,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":["share split"],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱パン・パシフィック・インターナショナルＨＤ","held_name_en":null,"held_sec_code":null,"match_status":"unmatched","shares":240000,"book_value_yen":232000000,"prior_shares":48000,"prior_book_value_yen":196000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、株式分割により保有株式数が増加しております。","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":null,"pct_share_classes":null,"pct_of_holder_equity":0.6790376397588246,"pct_of_holder_assets":0.15634160641000586,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":["share split"],"note_refs":[],"share_ratio":5.0,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"明治ホールディングス㈱","held_name_en":"Meiji Holdings Co.,Ltd.","held_sec_code":"2269","match_status":"matched","shares":45492,"book_value_yen":175000000,"prior_shares":45492,"prior_book_value_yen":147000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無(注１)","pct_outstanding":0.01678039999704908,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.5122051161973892,"pct_of_holder_assets":0.11793009104203028,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱ツムラ","held_name_en":"TSUMURA & CO.","held_sec_code":"4540","match_status":"matched","shares":42900,"book_value_yen":160000000,"prior_shares":42900,"prior_book_value_yen":185000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"有","pct_outstanding":0.05698129666638694,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.4683018205233273,"pct_of_holder_assets":0.10782179752414198,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱クリエイトＳＤホールディングス","held_name_en":"CREATE SD HOLDINGS CO.,LTD.","held_sec_code":"3148","match_status":"matched","shares":40811,"book_value_yen":134000000,"prior_shares":39822,"prior_book_value_yen":115000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、新規商品・カテゴリーの導入等に伴う、より一層の取引関係や協力関係の強化を図るため、取引先持株会を通じて保有株式数が増加しております。","reciprocal":"無","pct_outstanding":0.06317263234822044,"pct_unavailable":null,"pct_basis_period_end":"2026-05-31","pct_share_classes":1,"pct_of_holder_equity":0.3922027746882866,"pct_of_holder_assets":0.0903007554264689,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱みずほフィナンシャルグループ","held_name_en":"Mizuho Financial Group, Inc.","held_sec_code":"8411","match_status":"matched","shares":20413,"book_value_yen":124000000,"prior_shares":20413,"prior_book_value_yen":82000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な借入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無(注１)","pct_outstanding":0.000835983640642566,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.36293391090557864,"pct_of_holder_assets":0.08356189308121004,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"小林製薬㈱","held_name_en":"KOBAYASHI PHARMACEUTICAL CO.,LTD.","held_sec_code":"4967","match_status":"matched","shares":19988,"book_value_yen":117000000,"prior_shares":19276,"prior_book_value_yen":109000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、新規商品・カテゴリーの導入等に伴う、より一層の取引関係や協力関係の強化を図るため、取引先持株会を通じて保有株式数が増加しております。","reciprocal":"有","pct_outstanding":0.026887708706624266,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":0.34244570625768306,"pct_of_holder_assets":0.07884468943952883,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱セブン＆アイ・ホールディングス","held_name_en":"Seven & i Holdings Co., Ltd.","held_sec_code":"3382","match_status":"matched","shares":44344,"book_value_yen":94000000,"prior_shares":43460,"prior_book_value_yen":94000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、新規商品・カテゴリーの導入等に伴う、より一層の取引関係や協力関係の強化を図るため、取引先持株会を通じて保有株式数が増加しております。","reciprocal":"無","pct_outstanding":0.0019156957783673803,"pct_unavailable":null,"pct_basis_period_end":"2026-02-28","pct_share_classes":1,"pct_of_holder_equity":0.2751273195574548,"pct_of_holder_assets":0.06334530604543341,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱ライフコーポレーション","held_name_en":"LIFE CORPORATION","held_sec_code":"8194","match_status":"matched","shares":35908,"book_value_yen":91000000,"prior_shares":34857,"prior_book_value_yen":67000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、新規商品・カテゴリーの導入等に伴う、より一層の取引関係や協力関係の強化を図るため、取引先持株会を通じて保有株式数が増加しております。","reciprocal":"無","pct_outstanding":0.04142655577437133,"pct_unavailable":null,"pct_basis_period_end":"2026-02-28","pct_share_classes":1,"pct_of_holder_equity":0.2663466604226424,"pct_of_holder_assets":0.06132364734185575,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱バローホールディングス","held_name_en":"VALOR HOLDINGS CO.,LTD.","held_sec_code":"9956","match_status":"matched","shares":20000,"book_value_yen":73000000,"prior_shares":20000,"prior_book_value_yen":47000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.037969613639626865,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.21366270561376807,"pct_of_holder_assets":0.04919369512038978,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱フジ","held_name_en":"ＦＵＪＩ　ＣＯ．，ＬＴＤ．","held_sec_code":"8278","match_status":"matched","shares":28954,"book_value_yen":60000000,"prior_shares":28024,"prior_book_value_yen":60000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、新規商品・カテゴリーの導入等に伴う、より一層の取引関係や協力関係の強化を図るため、取引先持株会を通じて保有株式数が増加しております。","reciprocal":"無","pct_outstanding":0.03334601957775513,"pct_unavailable":null,"pct_basis_period_end":"2026-02-28","pct_share_classes":1,"pct_of_holder_equity":0.17561318269624773,"pct_of_holder_assets":0.04043317407155324,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"不二ラテックス㈱","held_name_en":"FUJI LATEX CO., LTD.","held_sec_code":"5199","match_status":"matched","shares":27500,"book_value_yen":55000000,"prior_shares":27500,"prior_book_value_yen":47000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"有","pct_outstanding":2.1696269582855687,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.16097875080489377,"pct_of_holder_assets":0.03706374289892381,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱イズミ","held_name_en":"IZUMI CO., LTD.","held_sec_code":"8273","match_status":"matched","shares":52200,"book_value_yen":54000000,"prior_shares":17400,"prior_book_value_yen":55000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。・2025年度は、株式分割により保有株式数が増加しております。 ","reciprocal":"無","pct_outstanding":null,"pct_unavailable":"holding restated onto a share base the issuer has not filed yet","pct_basis_period_end":"2026-02-28","pct_share_classes":1,"pct_of_holder_equity":0.15805186442662295,"pct_of_holder_assets":0.03638985666439792,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":["share split"],"note_refs":[],"share_ratio":3.0,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"三井住友トラストグループ㈱","held_name_en":"Sumitomo Mitsui Trust Group, Inc.","held_sec_code":"8309","match_status":"matched","shares":9600,"book_value_yen":47000000,"prior_shares":9600,"prior_book_value_yen":35000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な借入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無(注１)","pct_outstanding":0.0013748913728402067,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.1375636597787274,"pct_of_holder_assets":0.031672653022716706,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"スギホールディングス㈱","held_name_en":"SUGI HOLDINGS CO.,LTD.","held_sec_code":"7649","match_status":"matched","shares":12000,"book_value_yen":41000000,"prior_shares":12000,"prior_book_value_yen":33000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.006630826533522027,"pct_unavailable":null,"pct_basis_period_end":"2026-02-28","pct_share_classes":1,"pct_of_holder_equity":0.12000234150910262,"pct_of_holder_assets":0.02762933561556138,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"武田薬品工業㈱","held_name_en":"Takeda Pharmaceutical Company Limited","held_sec_code":"4502","match_status":"matched","shares":6652,"book_value_yen":37000000,"prior_shares":6652,"prior_book_value_yen":29000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.00041970071920292547,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.10829479599601943,"pct_of_holder_assets":0.02493379067745783,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱True Date","held_name_en":null,"held_sec_code":null,"match_status":"foreign","shares":72500,"book_value_yen":32000000,"prior_shares":72500,"prior_book_value_yen":50000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、EDIのプラットフォームの提供等に関して、当社グループの事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":null,"pct_share_classes":null,"pct_of_holder_equity":0.09366036410466545,"pct_of_holder_assets":0.021564359504828396,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱メディパルホールディングス","held_name_en":"MEDIPAL HOLDINGS CORPORATION","held_sec_code":"7459","match_status":"matched","shares":10000,"book_value_yen":29000000,"prior_shares":10000,"prior_book_value_yen":23000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.0048852302596125675,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.08487970496985307,"pct_of_holder_assets":0.019542700801250732,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"堺化学工業㈱","held_name_en":"SAKAI CHEMICAL INDUSTRY CO., LTD.","held_sec_code":"4078","match_status":"matched","shares":7200,"book_value_yen":24000000,"prior_shares":7200,"prior_book_value_yen":19000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無(注１)","pct_outstanding":0.0470244004388944,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0702452730784991,"pct_of_holder_assets":0.016173269628621294,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱三井住友フィナンシャルグループ","held_name_en":"Sumitomo Mitsui Financial Group, Inc.","held_sec_code":"8316","match_status":"matched","shares":3084,"book_value_yen":15000000,"prior_shares":3084,"prior_book_value_yen":11000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な借入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無(注１)","pct_outstanding":8.078712774161229e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.04390329567406193,"pct_of_holder_assets":0.01010829351788831,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"アルフレッサホールディングス㈱","held_name_en":"Alfresa Holdings Corporation","held_sec_code":"2784","match_status":"matched","shares":4680,"book_value_yen":11000000,"prior_shares":4680,"prior_book_value_yen":9000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.002568573503188489,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.03219575016097875,"pct_of_holder_assets":0.00741274857978476,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱プラネット","held_name_en":"PLANET, INC.","held_sec_code":"2391","match_status":"matched","shares":8000,"book_value_yen":9000000,"prior_shares":8000,"prior_book_value_yen":10000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、EDIのプラットフォームの提供等に関して、当社グループの事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.12209639510393455,"pct_unavailable":null,"pct_basis_period_end":"2026-07-31","pct_share_classes":1,"pct_of_holder_equity":0.02634197740443716,"pct_of_holder_assets":0.006064976110732986,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"アサヒグループホールディングス㈱","held_name_en":"Asahi Group Holdings, Ltd.","held_sec_code":"2502","match_status":"matched","shares":5097,"book_value_yen":8000000,"prior_shares":5097,"prior_book_value_yen":9000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無(注１)","pct_outstanding":0.0003484321067215673,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":0.023415091026166363,"pct_of_holder_assets":0.005391089876207099,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"アステナホールディングス㈱","held_name_en":"Astena Holdings Co., Ltd.","held_sec_code":"8095","match_status":"matched","shares":10000,"book_value_yen":4000000,"prior_shares":10000,"prior_book_value_yen":4000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社グループは、当社グループにおける仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.024377361953071334,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.011707545513083182,"pct_of_holder_assets":0.0026955449381035495,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"わかもと製薬㈱","held_name_en":"WAKAMOTO PHARMACEUTICAL CO.,LTD.","held_sec_code":"4512","match_status":"matched","shares":9539,"book_value_yen":3000000,"prior_shares":9125,"prior_book_value_yen":2000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける主要な仕入先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ・2025年度は、新規商品・カテゴリーの導入等に伴う、より一層の取引関係や協力関係の強化を図るため、取引先持株会を通じて保有株式数が増加しております。","reciprocal":"有","pct_outstanding":0.02748522046307655,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.008780659134812387,"pct_of_holder_assets":0.002021658703577662,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"㈱コスモス薬品","held_name_en":"COSMOS Pharmaceutical Corporation","held_sec_code":"3349","match_status":"matched","shares":400,"book_value_yen":2000000,"prior_shares":400,"prior_book_value_yen":3000000,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける主要な販売先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.0005046853728300106,"pct_unavailable":null,"pct_basis_period_end":"2026-05-31","pct_share_classes":1,"pct_of_holder_equity":0.005853772756541591,"pct_of_holder_assets":0.0013477724690517748,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"丸三証券㈱","held_name_en":"Marusan Securities Co., Ltd.","held_sec_code":"8613","match_status":"matched","shares":1102,"book_value_yen":1000000,"prior_shares":1102,"prior_book_value_yen":0,"purpose_ja":"・同社株式は、当社グループの事業活動の円滑化のため保有しております。・同社は、当社グループにおける株式の預け先であり、当社の事業継続に不可欠な取引先であります。・当社グループは保有株式について、配当・取引額に加え、経営戦略上の重要性や事業上の関係等を総合的に判断し、保有の便益とリスクの見合いを勘案し保有しております。定量的な保有効果については、取引先との関係性を考慮し記載しませんが、上記方針に基づいて総合的に保有効果を判断しております。 ","reciprocal":"無","pct_outstanding":0.0016618770325004936,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0029268863782707954,"pct_of_holder_assets":0.0006738862345258874,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"三菱ケミカルグループ㈱","held_name_en":"Mitsubishi Chemical Group Corporation","held_sec_code":"4188","match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":17200,"prior_book_value_yen":12000000,"purpose_ja":"当事業年度において、全株式を売却しております。","reciprocal":"無(注１)","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"養命酒製造㈱","held_name_en":"YOMEISHU SEIZO CO., LTD.","held_sec_code":"2540","match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":2500,"prior_book_value_yen":7000000,"purpose_ja":"当事業年度において、全株式を売却しております。","reciprocal":"有","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"久光製薬㈱","held_name_en":"HISAMITSU PHARMACEUTICAL CO.,INC.","held_sec_code":null,"match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":127429,"prior_book_value_yen":515000000,"purpose_ja":"当事業年度において、全株式を売却しております。","reciprocal":"有","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2025-02-28","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"largest","held_name_raw":"川本産業㈱","held_name_en":"KAWAMOTO CORPORATION","held_sec_code":null,"match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":26200,"prior_book_value_yen":31000000,"purpose_ja":"当事業年度において、全株式を売却しております。","reciprocal":"有","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":null,"pct_share_classes":null,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34166000000,"holder_total_assets_yen":148393000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false}],"holders":[{"holder_name":"ロート製薬株式会社","holder_name_en":"ROHTO PHARMACEUTICAL CO.,LTD.","holder_sec_code":"4527","doc_id":"S100YE5N","period_end":"2026-03-31","holder_table":"reporting","shares":1759530,"book_value_yen":2341000000,"prior_shares":1759527,"prior_book_value_yen":1409000000,"purpose_ja":"同社は、主要販売代理店としており、流通管理の適正化（過剰流通・不正転売防止等）を含めた取引関係の維持・強化を通じて、中長期的な企業価値の向上を図ることを目的として、同社株式を保有しております。なお、株式数は取引先持株会における配当金再投資による買付により増加しています。 ","reciprocal":"無","pct_outstanding":12.901671799384074,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.7311649290698183,"pct_of_holder_assets":0.48191431765173304,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":320174000000,"holder_total_assets_yen":485771000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"東邦ホールディングス株式会社","holder_name_en":"TOHO HOLDINGS CO.,LTD.","holder_sec_code":"8129","doc_id":"S100YHSN","period_end":"2026-03-31","holder_table":"reporting","shares":1413000,"book_value_yen":1880000000,"prior_shares":1413000,"prior_book_value_yen":1131000000,"purpose_ja":"同上","reciprocal":"有","pct_outstanding":10.360756709194897,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.6922963617616733,"pct_of_holder_assets":0.2537862067196648,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":271560000000,"holder_total_assets_yen":740781000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社ツムラ","holder_name_en":"TSUMURA & CO.","holder_sec_code":"4540","doc_id":"S100YFC1","period_end":"2026-03-31","holder_table":"reporting","shares":559046,"book_value_yen":744000000,"prior_shares":559046,"prior_book_value_yen":447000000,"purpose_ja":"医薬品販売等の取引関係を維持・強化し、中長期的な企業価値の向上のため保有しており、当社の資本コストと配当金・取引額の比較等により、当社に便益があることを確認しています。","reciprocal":"無(注)２","pct_outstanding":4.099178765214841,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.20021366888857195,"pct_of_holder_assets":0.12551327167887497,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":371603000000,"holder_total_assets_yen":592766000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"明治ホールディングス株式会社","holder_name_en":"Meiji Holdings Co.,Ltd.","holder_sec_code":"2269","doc_id":"S100YILP","period_end":"2026-03-31","holder_table":"second_largest","shares":318607,"book_value_yen":424000000,"prior_shares":318607,"prior_book_value_yen":255000000,"purpose_ja":"食品セグメントにおける販売先であり、取引関係の強化のため保有しております。","reciprocal":"無","pct_outstanding":2.336170992814196,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.051862144548603634,"pct_of_holder_assets":0.03360388156533855,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":817552000000,"holder_total_assets_yen":1261759000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"久光製薬株式会社","holder_name_en":"HISAMITSU PHARMACEUTICAL CO.,INC.","holder_sec_code":"4530","doc_id":"S100VT69","period_end":"2025-02-28","holder_table":"reporting","shares":467026,"book_value_yen":400000000,"prior_shares":463448,"prior_book_value_yen":469000000,"purpose_ja":"医薬品事業の販売先であり、取引関係維持・強化を図るため。取引先持株会を通じた取得による増加。","reciprocal":"有","pct_outstanding":3.4244212903556948,"pct_unavailable":null,"pct_basis_period_end":"2025-03-31","pct_share_classes":1,"pct_of_holder_equity":0.1431603359973086,"pct_of_holder_assets":0.1165949607657957,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":279407000000,"holder_total_assets_yen":343068000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"小林製薬株式会社","holder_name_en":"KOBAYASHI PHARMACEUTICAL CO.,LTD.","holder_sec_code":"4967","doc_id":"S100XSXS","period_end":"2025-12-31","holder_table":"reporting","shares":209758,"book_value_yen":298000000,"prior_shares":205817,"prior_book_value_yen":167000000,"purpose_ja":"当社製品の主要代理店であり、協力関係を維持していくために保有しており、取引先持株会による定期買付のため株式数が増加しております。","reciprocal":"有","pct_outstanding":1.5380407684411204,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.141226872914771,"pct_of_holder_assets":0.10823414896360355,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":211008000000,"holder_total_assets_yen":275329000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"アース製薬株式会社","holder_name_en":"Earth Corporation","holder_sec_code":"4985","doc_id":"S100XSLS","period_end":"2025-12-31","holder_table":"reporting","shares":200000,"book_value_yen":284000000,"prior_shares":200000,"prior_book_value_yen":163000000,"purpose_ja":"当社製品の卸売を行っており、安定的・中長期的な営業取引関係の維持・強化を目的に保有しております。","reciprocal":"無","pct_outstanding":1.4664906877841326,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.3493664657399434,"pct_of_holder_assets":0.19011661378211564,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":81290000000,"holder_total_assets_yen":149382000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"養命酒製造株式会社","holder_name_en":"YOMEISHU SEIZO CO., LTD.","holder_sec_code":"2540","doc_id":"S100YK3W","period_end":"2026-03-31","holder_table":"reporting","shares":118082,"book_value_yen":157167000,"prior_shares":118061,"prior_book_value_yen":94567000,"purpose_ja":"安定的な販売取引関係の維持・強化を目的に株式を保有しております。また、取引先持株会の会員としての取得により株式が増加しております。","reciprocal":"無","pct_outstanding":0.8658307669746297,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.3391193882917751,"pct_of_holder_assets":0.2908028983150151,"holder_equity_basis":"parent_only","holder_equity_yen":46345625000,"holder_total_assets_yen":54045885000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"大塚ホールディングス株式会社","holder_name_en":"Otsuka Holdings Co., Ltd.","holder_sec_code":"4578","doc_id":"S100XUA7","period_end":"2025-12-31","holder_table":"largest","shares":99125,"book_value_yen":140000000,"prior_shares":99125,"prior_book_value_yen":80000000,"purpose_ja":"同社が有する全国規模のドラッグストア向け販売網と製品供給機能を通じて、ニュートラシューティカルズ関連製品の安定的な販売チャネルを確保しています。これらの協働は、大塚製薬㈱製品の市場浸透及び流通効率の向上に寄与し、大塚製薬㈱グループの事業基盤及び企業価値の向上に資することから、同社株式を保有しております。保有の合理性については、毎年取締役会で経済合理性及び定性的保有意義の観点から総合的に保有の妥当性を検証しています。","reciprocal":"有","pct_outstanding":0.7268294471330107,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.004615216236066992,"pct_of_holder_assets":0.003335269377795968,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":3033444000000,"holder_total_assets_yen":4197562000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"わかもと製薬株式会社","holder_name_en":"WAKAMOTO PHARMACEUTICAL CO.,LTD.","holder_sec_code":"4512","doc_id":"S100YDBU","period_end":"2026-03-31","holder_table":"reporting","shares":95022,"book_value_yen":126474000,"prior_shares":92632,"prior_book_value_yen":74198000,"purpose_ja":"同社傘下の企業がヘルスケア事業における顧客であり、取引関係の維持・強化のため保有しています。また、取引先持株会において継続的に取得しているため株式数が増加しています。","reciprocal":"有","pct_outstanding":0.6967443906731192,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.0531968764669197,"pct_of_holder_assets":0.7665273481968389,"holder_equity_basis":"parent_only","holder_equity_yen":12008581000,"holder_total_assets_yen":16499607000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"森永乳業株式会社","holder_name_en":"Morinaga Milk Industry Co., Ltd.","holder_sec_code":"2264","doc_id":"S100YIHY","period_end":"2026-03-31","holder_table":"reporting","shares":88451,"book_value_yen":117000000,"prior_shares":88451,"prior_book_value_yen":70000000,"purpose_ja":"ＢｔｏＣ事業を始めとした営業取引における企業間取組の強化・推進のため。","reciprocal":"無","pct_outstanding":0.6485628391259716,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.04182320580234424,"pct_of_holder_assets":0.0213848617112276,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":279749000000,"holder_total_assets_yen":547116000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"ハウス食品グループ本社株式会社","holder_name_en":"HOUSE FOODS GROUP INC.","holder_sec_code":"2810","doc_id":"S100YD7A","period_end":"2026-03-31","holder_table":"reporting","shares":74300,"book_value_yen":99000000,"prior_shares":73198,"prior_book_value_yen":59000000,"purpose_ja":"製品販売における協力関係の維持・強化を目的として保有しております。また、当事業年度末時点において含み益を計上し、配当額は２百万円となります。なお、取引先持株会において継続的に取得し、株式数が増加しておりますが、当事業年度において取引先持株会を退会しております。","reciprocal":"無","pct_outstanding":0.5448012905118053,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.030677222936646886,"pct_of_holder_assets":0.022640214967697674,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":322715000000,"holder_total_assets_yen":437275000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"フマキラー株式会社","holder_name_en":"FUMAKILLA LIMITED","holder_sec_code":"4998","doc_id":"S100YGPK","period_end":"2026-03-31","holder_table":"reporting","shares":53151,"book_value_yen":70000000,"prior_shares":53151,"prior_book_value_yen":42000000,"purpose_ja":"販売取引関係の維持・発展のため（定量的な保有効果）（注）","reciprocal":"無","pct_outstanding":0.38972723273207216,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.23868789852354486,"pct_of_holder_assets":0.10210630725246514,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":29327000000,"holder_total_assets_yen":68556000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"田辺三菱製薬株式会社","holder_name_en":"Mitsubishi Tanabe Pharma Corporation","holder_sec_code":"4508","doc_id":"S100G3TB","period_end":"2019-03-31","holder_table":"reporting","shares":67252,"book_value_yen":67000000,"prior_shares":67252,"prior_book_value_yen":113000000,"purpose_ja":null,"reciprocal":"無","pct_outstanding":0.4807594701437589,"pct_unavailable":null,"pct_basis_period_end":"2019-03-31","pct_share_classes":1,"pct_of_holder_equity":0.007464316112673295,"pct_of_holder_assets":0.006342979079529597,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":897604000000,"holder_total_assets_yen":1056286000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"参天製薬株式会社","holder_name_en":"SANTEN PHARMACEUTICAL CO., LTD.","holder_sec_code":"4536","doc_id":"S100YDH1","period_end":"2026-03-31","holder_table":"reporting","shares":49509,"book_value_yen":66000000,"prior_shares":49509,"prior_book_value_yen":40000000,"purpose_ja":"当社医薬品等の販売契約があり、眼科領域における事業関係の強化を図ることを目的に保有しています。（注）","reciprocal":"無","pct_outstanding":0.3630224373075231,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.022223045297974,"pct_of_holder_assets":0.015601619731793973,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":296989000000,"holder_total_assets_yen":423033000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"川本産業株式会社","holder_name_en":"KAWAMOTO CORPORATION","holder_sec_code":"3604","doc_id":"S100TT3D","period_end":"2024-03-31","holder_table":"reporting","shares":40000,"book_value_yen":39600000,"prior_shares":40000,"prior_book_value_yen":32480000,"purpose_ja":"同社傘下の企業は当社の販売先であり、良好な取引関係の維持、強化を目的として保有しております。","reciprocal":"無","pct_outstanding":0.2932959869776582,"pct_unavailable":null,"pct_basis_period_end":"2024-03-31","pct_share_classes":1,"pct_of_holder_equity":0.510917836799683,"pct_of_holder_assets":0.20256390661067308,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":7750757000,"holder_total_assets_yen":19549386000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"森永製菓株式会社","holder_name_en":"Morinaga＆Co., Ltd.","holder_sec_code":"2201","doc_id":"S100YHJS","period_end":"2026-03-31","holder_table":"reporting","shares":26431,"book_value_yen":35000000,"prior_shares":25626,"prior_book_value_yen":20000000,"purpose_ja":"食料品製造事業における得意先であり、製品販売の安定的な営業取引の維持・強化を目的として保有しております。また、同社の取引先持株会に加入しており、中長期的に良好な営業取引関係の維持を目的とした、定期購入による増加であります。","reciprocal":"無","pct_outstanding":0.19380407684411205,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.02435697583787997,"pct_of_holder_assets":0.015492141058157497,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":143696000000,"holder_total_assets_yen":225921000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"センコーグループホールディングス株式会社","holder_name_en":"SENKO Group Holdings Co., Ltd.","holder_sec_code":"9069","doc_id":"S100YH4R","period_end":"2026-03-31","holder_table":"reporting","shares":21358,"book_value_yen":28000000,"prior_shares":20477,"prior_book_value_yen":16000000,"purpose_ja":"（保有目的）取引先との円滑で長期的な関係の構築のため（業務提携等の概要）物流業務等の取引（株式数が増加した理由）取引先持株会を通じた株式の取得","reciprocal":"無","pct_outstanding":0.1566065405484675,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.010598874248142359,"pct_of_holder_assets":0.0034062431571008005,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":264179000000,"holder_total_assets_yen":822020000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"ライオン株式会社","holder_name_en":"Lion Corporation","holder_sec_code":"4912","doc_id":"S100XU1E","period_end":"2025-12-31","holder_table":"reporting","shares":10500,"book_value_yen":14000000,"prior_shares":10500,"prior_book_value_yen":8000000,"purpose_ja":"主に一般用消費財事業における製品販売等の取引先であり、同社との取引関係の維持・強化のため保有しております。","reciprocal":"無","pct_outstanding":0.07699076110866696,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.004338045276798275,"pct_of_holder_assets":0.002648525528002482,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":322726000000,"holder_total_assets_yen":528596000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"エステー株式会社","holder_name_en":"S.T.CORPORATION","holder_sec_code":"4951","doc_id":"S100YD9M","period_end":"2026-03-31","holder_table":"reporting","shares":11000,"book_value_yen":14000000,"prior_shares":11000,"prior_book_value_yen":8000000,"purpose_ja":"当社製品の卸売を行っており、取引関係の維持及び強化を目的に、取引に係る当社利益等を総合的に判断し保有しています。","reciprocal":"無","pct_outstanding":0.08065698782812729,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.04081275690172871,"pct_of_holder_assets":0.030413625304136254,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":34303000000,"holder_total_assets_yen":46032000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"不二ラテックス株式会社","holder_name_en":"FUJI LATEX CO., LTD.","holder_sec_code":"5199","doc_id":"S100YGMK","period_end":"2026-03-31","holder_table":"reporting","shares":6250,"book_value_yen":8000000,"prior_shares":6250,"prior_book_value_yen":5000000,"purpose_ja":"・医療機器事業において取引関係にあり、医療衛生卸と異なる販路を有していることから販売機会の増大を目的として保有しております。・定量的効果を含む総合的な保有判断基準を満たしております。","reciprocal":"無","pct_outstanding":0.045827833993254144,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.19768276265614468,"pct_of_holder_assets":0.07789630891261329,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":4046888000,"holder_total_assets_yen":10270063000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"ゼリア新薬工業株式会社","holder_name_en":"ZERIA PHARMACEUTICAL CO., LTD.","holder_sec_code":"4559","doc_id":"S100YKC2","period_end":"2026-03-31","holder_table":"reporting","shares":1050,"book_value_yen":1397000,"prior_shares":1050,"prior_book_value_yen":841000,"purpose_ja":"（保有目的）コンシューマーヘルスケア事業活動の円滑な推進（定量的な保有効果）（注）１","reciprocal":"無","pct_outstanding":0.007699076110866696,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0012863152720980354,"pct_of_holder_assets":0.0007774156621008512,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":108604790000,"holder_total_assets_yen":179697949000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"テルモ株式会社","holder_name_en":"TERUMO CORPORATION","holder_sec_code":"4543","doc_id":"S100YGMG","period_end":"2026-03-31","holder_table":"reporting","shares":1050,"book_value_yen":1000000,"prior_shares":1050,"prior_book_value_yen":0,"purpose_ja":"主にメディカルケアソリューションズカンパニーにおける代理店取引関係維持・強化のため保有しております。","reciprocal":"無","pct_outstanding":0.007699076110866696,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":6.31110331339235e-05,"pct_of_holder_assets":4.3248217957179076e-05,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":1584509000000,"holder_total_assets_yen":2312234000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"富士フイルムホールディングス株式会社","holder_name_en":"FUJIFILM Holdings Corporation","holder_sec_code":"4901","doc_id":"S100YIBH","period_end":"2026-03-31","holder_table":"second_largest","shares":null,"book_value_yen":null,"prior_shares":34300,"prior_book_value_yen":27000000,"purpose_ja":"・当事業年度において売却しました。","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"usgaap_consolidated","holder_equity_yen":3844385000000,"holder_total_assets_yen":6053776000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"丸三証券株式会社","holder_name_en":"Marusan Securities Co., Ltd.","holder_sec_code":"8613","doc_id":"S100YC95","period_end":"2026-03-31","holder_table":"reporting","shares":null,"book_value_yen":null,"prior_shares":1000,"prior_book_value_yen":0,"purpose_ja":"当事業年度において保有株式を売却しております。","reciprocal":"無(注)９","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"parent_only","holder_equity_yen":51444000000,"holder_total_assets_yen":88476000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"雪印メグミルク株式会社","holder_name_en":"MEGMILK SNOW BRAND Co.,Ltd.","holder_sec_code":"2270","doc_id":"S100YC5I","period_end":"2026-03-31","holder_table":"reporting","shares":null,"book_value_yen":null,"prior_shares":51052,"prior_book_value_yen":40000000,"purpose_ja":"当事業年度において株式の売却を実施しております。","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":240741000000,"holder_total_assets_yen":426820000000,"implausible":false,"reciprocal_held_both_ways":false}],"reclassified":[],"reclassified_note":"As filed, from the annual report's 保有目的を変更した投資株式 table. direction=to_pure means the filer moved the holding from a policy shareholding to 純投資目的 (pure investment); the shares are not necessarily sold, and the position leaves the named policy table in the year of the change. direction=to_policy is the reverse. fy_of_change_ja is the fiscal year the filer states the change took effect, verbatim — some filers list more than one. A filing repeats these rows for several years after the change, so this is a standing disclosure, not a one-year event.","implausible_note":"A row is flagged implausible when its two filed numbers are mutually impossible — book value ÷ shares of ¥1,000,000 or more, which no listed Japanese share reaches. It is a filer tagging error (a value entered at the wrong scale, or a share count in thousands), not an extraction error: the values match the filing's XBRL exactly. Flagged rows are still returned, exactly as filed, but are excluded from the yen aggregates here and counted in excluded_positions / excluded_yen so the exclusion is visible.","notes":[{"holder_table":"largest","note_no":"1","text_ja":"(注) １　保有先企業は当社の株式を保有しておりませんが、同社子会社が当社の株式を保有しております。"}],"notes_note":"The filing's own numbered footnotes to the named policy table, verbatim. The XBRL numbers them (注)1, (注)2 … and gives no link back to a row, so a note is tied to a position only where it names that issuer.","flows":[{"holder_table":"largest","share_class":"listed","issues_increased":9,"acquisition_cost_yen":32000000,"issues_decreased":5,"sale_proceeds_yen":846000000,"entity_scope":"largest_holding_company","share_scope":"listed"},{"holder_table":"largest","share_class":"unlisted","issues_increased":null,"acquisition_cost_yen":null,"issues_decreased":1,"sale_proceeds_yen":2000000,"entity_scope":"largest_holding_company","share_scope":"unlisted"},{"holder_table":"reporting","share_class":"listed","issues_increased":null,"acquisition_cost_yen":null,"issues_decreased":null,"sale_proceeds_yen":null,"entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","issues_increased":1,"acquisition_cost_yen":46000000,"issues_decreased":null,"sale_proceeds_yen":null,"entity_scope":"parent_only","share_scope":"unlisted"}],"flows_note":"The filer's own tally, as filed, of how many issues increased or decreased during the year and the yen involved — acquisition cost for increases, sale proceeds for decreases. Read against the reclassification table this separates what was actually sold from what merely changed category. Counts are as filed and are not corrected for filer tagging errors.","no_reduction_measure":"This product holds sale proceeds (売却価額), as filed, for one fiscal year. It does NOT hold a book-value-reduction measure. The two are different measures and must never be presented as equivalent.","scale":{"policy_total_yen":14515000000,"listed_yen":14268000000,"unlisted_yen":247000000,"listed_issues":32,"unlisted_issues":13,"equity_yen":34166000000,"equity_basis":"jgaap_consolidated","total_assets_yen":148393000000,"assets_basis":"jgaap_consolidated","pct_of_equity":42.483755780600596,"pct_of_assets":9.781458694143256,"equity_basis_label":"Consolidated net assets (Japanese GAAP)","assets_basis_label":"Consolidated net assets (Japanese GAAP)","equity_calc":"total policy shareholdings ÷ shareholders' equity × 100, both as filed in this annual securities report","assets_calc":"total policy shareholdings ÷ total assets × 100, both as filed in this annual securities report"},"scale_entities":[{"holder_table":"reporting","share_class":"unlisted","book_value_yen":66000000,"issue_count":3,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"unlisted"},{"holder_table":"largest","share_class":"listed","book_value_yen":14268000000,"issue_count":32,"holder_table_label":"Largest holder in the group","entity_scope":"largest_holding_company","share_scope":"listed"},{"holder_table":"largest","share_class":"unlisted","book_value_yen":181000000,"issue_count":10,"holder_table_label":"Largest holder in the group","entity_scope":"largest_holding_company","share_scope":"unlisted"}],"scale_history":[{"year":"2022","period_end":"2022-03-31","policy_total_yen":7123000000,"equity_yen":22092000000,"equity_basis":"jgaap_consolidated","pct_of_equity":32.242440702516745,"pct_of_assets":6.250767853695351},{"year":"2023","period_end":"2023-03-31","policy_total_yen":7516000000,"equity_yen":24271000000,"equity_basis":"jgaap_consolidated","pct_of_equity":30.966997651518273,"pct_of_assets":6.133557479659537},{"year":"2024","period_end":"2024-03-31","policy_total_yen":10262000000,"equity_yen":27899000000,"equity_basis":"jgaap_consolidated","pct_of_equity":36.78268038280942,"pct_of_assets":7.405322711003349},{"year":"2025","period_end":"2025-03-31","policy_total_yen":11653000000,"equity_yen":31055000000,"equity_basis":"jgaap_consolidated","pct_of_equity":37.523748188697475,"pct_of_assets":8.363057004858653},{"year":"2026","period_end":"2026-03-31","policy_total_yen":14515000000,"equity_yen":34166000000,"equity_basis":"jgaap_consolidated","pct_of_equity":42.483755780600596,"pct_of_assets":9.781458694143256}],"scale_note":"The policy total is Official (as filed) — the filing's own total carrying amount for the whole policy bucket, listed and unlisted, summed across the entities the filing discloses. It is a floor: holdings at group companies the filing does not name are disclosed nowhere and are not included. The percentages are calculated, not filed, and carry their formula. equity_basis names which figure the denominator is, because filers report under Japanese, IFRS or US accounting standards and an adopter of the latter two stops tagging the Japanese consolidated figure — a parent-only denominator is a different measure and is labelled as one, never silently mixed with a group figure. Percentages are null where equity or total assets is missing or not positive; missing is never shown as zero.","scale_reference":"ISS's Japan proxy voting guidelines recommend a vote against the top executive at a company that allocates 20 percent or more of its net assets to cross-shareholdings, a policy effective from February 2022. ISS counts unilateral holdings, not only mutual ones.","ownership_calc":"shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end","ownership_note":"Derived, not filed. The denominator is the issuer's own reported issued shares less treasury shares, from its annual report nearest this holding's fiscal year end on either side — pct_basis_period_end gives that date, and it can fall after the holding's date where that report is the closer one. For a single-class listed stock this equals the stake's share of market capitalisation. It is null where the issuer files no annual report we hold; where the issuer's share count moves by half or more across the window, because a split or issue makes the share base indeterminate; and where the result would exceed 100%, which is a data fault rather than a stake. It is less exact where the issuer has more than one share class (pct_share_classes > 1), because treasury shares are reported across all classes.","holder_share_calc":"this position's book value ÷ the holder's shareholders' equity (or total assets) × 100, both as filed in the holder's own annual securities report","holder_share_note":"The mirror of pct_outstanding. That sizes a stake against the ISSUER — how much of the issuer this holder owns. pct_of_holder_equity and pct_of_holder_assets size the same position against the HOLDER: how much of its own capital is committed to this one name. Calculated, not filed. Null where the holder's filing gives no usable denominator, never zero. holder_equity_basis says which accounting figure the denominator is, and a parent_only basis is not comparable with a consolidated one. A position CAN legitimately exceed 100% of equity — a holder whose book equity is smaller than one long-held stake is a real and commercially interesting case, not an error — so no ceiling is imposed. Extreme values are worth checking against the filing: where the position's own two filed numbers are mutually impossible the row is marked `implausible`, but that test catches only scale errors visible per share, so it does not catch every bad figure. The book value and share count are returned alongside so the reader can check.","action_calc":"keyword match over the filing's own stated purpose and table footnotes: 株式分割、株式併合、株式交換、株式移転、会社分割、合併、持株会社、商号変更、公開買付、上場廃止","ratio_calc":"current shares ÷ prior shares where that ratio is an exact whole number (or its exact reciprocal) — the signature of a split or a consolidation rather than a trade","history":[{"year":"2019","period_end":"2019-03-31","named_holdings":38,"book_value_yen":7241000000},{"year":"2022","period_end":"2022-03-31","named_holdings":38,"book_value_yen":6802000000},{"year":"2023","period_end":"2023-03-31","named_holdings":37,"book_value_yen":7192000000},{"year":"2024","period_end":"2024-03-31","named_holdings":38,"book_value_yen":10039000000},{"year":"2025","period_end":"2025-03-31","named_holdings":36,"book_value_yen":11405000000},{"year":"2026","period_end":"2026-03-31","named_holdings":36,"book_value_yen":14254000000}],"history_note":"One point per annual report filed. Each year's book value is as filed; book values are fair-valued at period end, so a change reflects both trading and market moves.","provenance":{"trust":"official","note":"Figures exactly as filed in each company's 有価証券報告書 (annual securities report), EDINET. Raw filings archived with SHA-256; doc_id links to the source filing."}}